Recommendations for insulin initiation based on ethnicity

Medical Hypotheses

Volumn 77, Issue 3, 2011, Pages 460-461

  John, M ^a   Kalra, S ^b   Unnikrishnan, A G ^c   Ganapathy, B ^d   Baruah, M P ^e   Sahay, R K ^f  

^a Providence Endocrine and Diabetes Specialty Centre   (India)

^b Bharti Hospital ^*  (India)

^c AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^d ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^e Excel Care Hospitals   (India)

^f OSMANIA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN GLARGINE;

ARTICLE; DIET; ETHNICITY; GENETIC VARIABILITY; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE;

DIABETES MELLITUS, TYPE 2; DIET; GENETIC VARIATION; GLUCOSE; HUMANS; INSULIN RESISTANCE; INSULINS; PRACTICE GUIDELINES AS TOPIC;

EID: 80051828370     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.06.010     Document Type: Article

References (18)

1. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(7258):405-412.
2. Cheung B.M., Ong K.L., Cherny S.S., Sham P.C., Tso A.W., Lam K.S. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med 2009, 122(5):443-453.
3. Horton E.S. Challenges and approaches to managing type 2 diabetes mellitus. Curr Diab Rep 2010, 10(1):7-9.
4. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32(1):193-203.
5. Riddle M.C., Rosenstock J., Gerich J. Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003, 26(11):3080-3086.
6. Philis-Tsimikas A., Charpentier G., Clauson P., Ravn G.M., Roberts V.L., Thorsteinsson B. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006, 28(10):1569-1581.
7. Malone J.K., Bai S., Campaigne B.N., Reviriego J., Augendre-Ferrante B. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes. Diabet Med 2005, 22(4):374-381.
8. Strojek K., Bebakar W.M., Khutsoane D.T., Pesic M., Smahelová A., Thomsen H.F., et al. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. Curr Med Res Opin 2009, 25(12):2887-2894.
9. Raskin P., Allen E., Hollander P., Lewin A., Gabbay R.A., Hu P., et al. INITIATE Study Group. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005, 28(2):260-265.
10. Saydah S., Cowie C., Eberhardt M.S., De Rekeneire N., Narayan K.M. Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis 2007, 17(3):529-535. [summer].
11. Haffner S.M., D'Agostino R., Saad M.F., et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The insulin resistance atherosclerosis study. Diabetes 1996, 45:742-748.
12. Arslanian S., Suprasongsin C., Janosky J.E. Insulin secretion and sensitivity in black versus white prepubertal healthy children. J Clin Endocrinol Metab 1997, 82:1923-1927.
13. Gower B.A., Nagy T.R., Goran M.I. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 1999, 48:1515-1521.
14. Ku C.Y., Gower B.A., Hunter G.R., Goran M.I. Racial differences in insulin secretion and sensitivity in prepubertal children: role of physical fitness and physical activity. Obes Res 2000, 8:506-515.
15. Goran M.I., Bergman R.N., Cruz M.L., Watanabe R. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 2002, 25:2184-2190.
16. Abate N., Chandalia M. Ethnicity, type 2 diabetes and migrant Asian Indians. Indian J Med Res 2007, 125(3):251-258.
17. Dickinson S., Colagiuri S., Faramus Petocz E., Brand-Miller J.C. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J Nutr 2002, 132:2574-2579.
18. Venn B.J., Williams S.M., Mann J.I. Comparison of postprandial glycaemia in Asians and Caucasians. Diabet Med 2010, 27(10):1205-1208.